A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

Clinical trial NCT00415311 · TERMINATED

Trial details

NCT number: NCT00415311
Sponsor: Enzon Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Transplantation

Start date: 2006-12-01
Primary completion: 2009-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.